TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Natera ( (NTRA) ) just unveiled an update.
On December 4, 2025, Natera, Inc. completed its acquisition of Foresight Diagnostics, a cancer diagnostics company specializing in molecular residual disease detection in B-cell lymphomas. This strategic acquisition, valued at $275 million upfront with potential earnouts, enhances Natera’s capabilities in personalized MRD testing and expands its intellectual property portfolio. The integration of Foresight’s phased variant technology into Natera’s Signatera platform is expected to strengthen test performance across solid tumors and accelerate MRD adoption in lymphoma. This move positions Natera at the forefront of precision oncology, promising improved value for patients, clinicians, and biopharma partners.
The most recent analyst rating on (NTRA) stock is a Buy with a $230.00 price target. To see the full list of analyst forecasts on Natera stock, see the NTRA Stock Forecast page.
Spark’s Take on NTRA Stock
According to Spark, TipRanks’ AI Analyst, NTRA is a Neutral.
Natera’s overall stock score is driven by strong earnings call results and positive technical analysis, indicating robust growth and market momentum. However, financial performance challenges and valuation concerns due to ongoing losses and a negative P/E ratio temper the overall score.
To see Spark’s full report on NTRA stock, click here.
More about Natera
Natera is a global leader in cell-free DNA and precision medicine, focusing on oncology, women’s health, and organ health. The company aims to integrate personalized genetic testing and diagnostics into standard healthcare practices to enable earlier and more targeted interventions. Natera operates ISO 13485-certified and CAP-accredited laboratories in Austin, Texas, and San Carlos, California.
Average Trading Volume: 1,333,880
Technical Sentiment Signal: Buy
Current Market Cap: $33.41B
See more insights into NTRA stock on TipRanks’ Stock Analysis page.